PubMed:15932919
Annnotations
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 142-158 | Cell | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL:0000066 |
T2 | 876-887 | Cell | denotes | cancer cell | http://purl.obolibrary.org/obo/CL:0001064 |
T3 | 1325-1347 | Cell | denotes | prostate stromal cells | http://purl.obolibrary.org/obo/CL:0002622 |
T4 | 1848-1860 | Cell | denotes | cancer cells | http://purl.obolibrary.org/obo/CL:0001064 |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 102-218 | DRI_Background | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
T2 | 219-268 | DRI_Outcome | denotes | Previously, we have shown that expression of core |
T3 | 290-384 | DRI_Outcome | denotes | is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
T4 | 385-571 | DRI_Outcome | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
T5 | 572-736 | DRI_Challenge | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
T6 | 737-893 | DRI_Approach | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
T7 | 894-1051 | DRI_Approach | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
T8 | 1052-1056 | DRI_Background | denotes | When |
T9 | 1080-1221 | DRI_Background | denotes | cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than |
T10 | 1245-1251 | DRI_Background | denotes | cells. |
T11 | 1252-1519 | DRI_Approach | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
T12 | 1520-1630 | DRI_Outcome | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
T13 | 1631-1881 | DRI_Background | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 14-20 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
T2 | 264-270 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
T3 | 428-434 | Glycan_Motif | denotes | core 2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00033MO |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
TextSentencer_T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
TextSentencer_T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
TextSentencer_T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
TextSentencer_T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
TextSentencer_T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
TextSentencer_T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
TextSentencer_T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
TextSentencer_T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
TextSentencer_T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
TextSentencer_T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 73-81 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T2 | 317-323 | http://purl.obolibrary.org/obo/MAT_0000393 | denotes | vessel |
T3 | 358-363 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colon |
T4 | 368-372 | http://purl.obolibrary.org/obo/MAT_0000135 | denotes | lung |
T5 | 537-545 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T6 | 696-704 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T7 | 784-792 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T8 | 867-875 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T9 | 1128-1136 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T10 | 1201-1209 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T11 | 1325-1333 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T12 | 1602-1610 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T13 | 1683-1691 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T14 | 1839-1847 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 29-60 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferase |
T2 | 443-474 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferase |
T3 | 29-60 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferase |
T4 | 443-474 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferase |
T5 | 29-60 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferase |
T6 | 443-474 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferase |
T7 | 264-279 | http://www.uniprot.org/uniprot/Q02742 | denotes | core 2-branched |
T8 | 696-721 | http://www.uniprot.org/uniprot/P07288 | denotes | prostate-specific antigen |
T9 | 723-726 | http://www.uniprot.org/uniprot/P07288 | denotes | PSA |
T10 | 696-721 | http://www.uniprot.org/uniprot/Q16305 | denotes | prostate-specific antigen |
T11 | 723-726 | http://www.uniprot.org/uniprot/Q9Y617 | denotes | PSA |
T12 | 723-726 | http://www.uniprot.org/uniprot/P55786 | denotes | PSA |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 29-60 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferase |
T2 | 443-474 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferase |
T3 | 723-726 | http://www.uniprot.org/uniprot/Q11011 | denotes | PSA |
T4 | 1140-1144 | http://www.uniprot.org/uniprot/Q9CZA6 | denotes | nude |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 82-88 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T2 | 153-158 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T3 | 373-383 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinomas |
T4 | 546-552 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T5 | 793-799 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T6 | 876-882 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T7 | 1080-1085 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T8 | 1166-1171 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T9 | 1245-1250 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T10 | 1294-1299 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T11 | 1342-1347 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T12 | 1398-1403 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T13 | 1434-1439 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T14 | 1611-1617 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T15 | 1692-1701 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
T16 | 1702-1707 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
T17 | 1848-1854 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
T18 | 1855-1860 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1809-1819 | http://purl.obolibrary.org/obo/GO_0002118 | denotes | aggressive |
T2 | 1826-1835 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-18 | http://purl.obolibrary.org/obo/GO_0019013 | denotes | core |
T2 | 264-268 | http://purl.obolibrary.org/obo/GO_0019013 | denotes | core |
T3 | 428-432 | http://purl.obolibrary.org/obo/GO_0019013 | denotes | core |
T4 | 102-106 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | Cell |
T5 | 153-158 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T6 | 1080-1085 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T7 | 1166-1171 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T8 | 1245-1250 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T9 | 1294-1299 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T10 | 1342-1347 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T11 | 1398-1403 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T12 | 1434-1439 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T13 | 1702-1707 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T14 | 883-887 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T15 | 102-114 | http://purl.obolibrary.org/obo/GO_0009986 | denotes | Cell surface |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 317-323 | http://purl.obolibrary.org/obo/UBERON_0000055 | denotes | vessel |
T2 | 358-363 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
T3 | 368-372 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
GlycoBiology-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 73-81 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T2 | 317-323 | http://purl.obolibrary.org/obo/MAT_0000393 | denotes | vessel |
T3 | 358-363 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colon |
T4 | 368-372 | http://purl.obolibrary.org/obo/MAT_0000135 | denotes | lung |
T5 | 537-545 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T6 | 696-704 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T7 | 784-792 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T8 | 867-875 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T9 | 1128-1136 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T10 | 1201-1209 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T11 | 1325-1333 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T12 | 1602-1610 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T13 | 1683-1691 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
T14 | 1839-1847 | http://purl.obolibrary.org/obo/MAT_0000078 | denotes | prostate |
Lectin
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
Lectin_T1 | 723-726 | https://acgg.asia/db/lfdb/LfDB0181 | denotes | PSA |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 368-372 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
PD-UBERON-AE-B_T2 | 317-323 | http://purl.obolibrary.org/obo/UBERON_0000055 | denotes | vessel |
PD-UBERON-AE-B_T3 | 358-363 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 73-88 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T2 | 200-205 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T3 | 368-383 | Disease | denotes | lung carcinomas | http://purl.obolibrary.org/obo/MONDO_0005138 |
T4 | 537-552 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T5 | 784-799 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T6 | 839-844 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T7 | 867-882 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T8 | 1201-1216 | Disease | denotes | prostate tumors | http://purl.obolibrary.org/obo/MONDO_0021259 |
T9 | 1602-1617 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T10 | 1683-1701 | Disease | denotes | prostate carcinoma | http://purl.obolibrary.org/obo/MONDO_0005159 |
T11 | 1820-1825 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T12 | 1839-1854 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 73-88 | Phenotype | denotes | prostate cancer | HP:0012125 |
T2 | 200-205 | Phenotype | denotes | tumor | HP:0002664 |
T3 | 373-383 | Phenotype | denotes | carcinomas | HP:0030731 |
T4 | 537-552 | Phenotype | denotes | prostate cancer | HP:0012125 |
T5 | 784-799 | Phenotype | denotes | prostate cancer | HP:0012125 |
T6 | 839-844 | Phenotype | denotes | tumor | HP:0002664 |
T7 | 867-882 | Phenotype | denotes | prostate cancer | HP:0012125 |
T8 | 1602-1617 | Phenotype | denotes | prostate cancer | HP:0012125 |
T9 | 1692-1701 | Phenotype | denotes | carcinoma | HP:0030731 |
T10 | 1809-1819 | Phenotype | denotes | aggressive | HP:0000718 |
T11 | 1820-1825 | Phenotype | denotes | tumor | HP:0002664 |
T12 | 1839-1854 | Phenotype | denotes | prostate cancer | HP:0012125 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 14-20 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
T2 | 264-270 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
T3 | 428-434 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 73-88 | Phenotype | denotes | prostate cancer | HP:0012125 |
T2 | 200-205 | Phenotype | denotes | tumor | HP:0002664 |
T3 | 373-383 | Phenotype | denotes | carcinomas | HP:0030731 |
T4 | 537-552 | Phenotype | denotes | prostate cancer | HP:0012125 |
T5 | 784-799 | Phenotype | denotes | prostate cancer | HP:0012125 |
T6 | 839-844 | Phenotype | denotes | tumor | HP:0002664 |
T7 | 867-882 | Phenotype | denotes | prostate cancer | HP:0012125 |
T8 | 1602-1617 | Phenotype | denotes | prostate cancer | HP:0012125 |
T9 | 1692-1701 | Phenotype | denotes | carcinoma | HP:0030731 |
T10 | 1820-1825 | Phenotype | denotes | tumor | HP:0002664 |
T11 | 1839-1854 | Phenotype | denotes | prostate cancer | HP:0012125 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 73-88 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T2 | 200-205 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T3 | 368-383 | Disease | denotes | lung carcinomas | http://purl.obolibrary.org/obo/MONDO_0005138 |
T4 | 537-552 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T5 | 784-799 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T6 | 839-844 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T7 | 867-882 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T8 | 1201-1216 | Disease | denotes | prostate tumors | http://purl.obolibrary.org/obo/MONDO_0021259 |
T9 | 1602-1617 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
T10 | 1683-1701 | Disease | denotes | prostate carcinoma | http://purl.obolibrary.org/obo/MONDO_0005159 |
T11 | 1820-1825 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
T12 | 1839-1854 | Disease | denotes | prostate cancer | http://purl.obolibrary.org/obo/MONDO_0008315 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 556-561 | OrganismTaxon | denotes | human | 9606 |
T2 | 1145-1149 | OrganismTaxon | denotes | mice | 10088 |
GlyCosmos15-CL
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 142-158 | Cell | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL:0000066 |
T2 | 876-887 | Cell | denotes | cancer cell | http://purl.obolibrary.org/obo/CL:0001064 |
T3 | 1325-1347 | Cell | denotes | prostate stromal cells | http://purl.obolibrary.org/obo/CL:0002622 |
T4 | 1848-1860 | Cell | denotes | cancer cells | http://purl.obolibrary.org/obo/CL:0001064 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 73-81 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T2 | 142-158 | Body_part | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL_0000066 |
T3 | 317-323 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/UBERON_0000055 |
T4 | 358-363 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T5 | 368-372 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T6 | 537-545 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T7 | 696-704 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T8 | 784-792 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T9 | 867-875 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T10 | 1128-1136 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T11 | 1201-1209 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T12 | 1325-1347 | Body_part | denotes | prostate stromal cells | http://purl.obolibrary.org/obo/CL_0002622 |
T13 | 1602-1610 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T14 | 1683-1691 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T15 | 1839-1847 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
GlyCosmos15-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 73-81 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T2 | 317-323 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/MAT_0000393 |
T3 | 358-363 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T4 | 368-372 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/MAT_0000135 |
T5 | 537-545 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T6 | 696-704 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T7 | 784-792 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T8 | 867-875 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T9 | 1128-1136 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T10 | 1201-1209 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T11 | 1325-1333 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T12 | 1602-1610 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T13 | 1683-1691 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T14 | 1839-1847 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
TextSentencer_T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
TextSentencer_T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
TextSentencer_T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
TextSentencer_T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
TextSentencer_T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
TextSentencer_T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
TextSentencer_T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
TextSentencer_T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
TextSentencer_T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
TextSentencer_T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-101 | Sentence | denotes | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression. |
T2 | 102-218 | Sentence | denotes | Cell surface carbohydrates expressed on epithelial cells are thought to play an important role in tumor progression. |
T3 | 219-384 | Sentence | denotes | Previously, we have shown that expression of core 2-branched O-glycans is closely correlated with vessel invasion and depth of invasion in colon and lung carcinomas. |
T4 | 385-571 | Sentence | denotes | In this study, we found that expression of core 2 beta1,6-N-acetylglucosaminyltransferase-1, Core2GnT, is positively correlated with the progression of prostate cancer in human patients. |
T5 | 572-736 | Sentence | denotes | Statistical analysis demonstrated that Core2GnT is an independent predictor for progressed pathological stage (pT3) and for prostate-specific antigen (PSA) relapse. |
T6 | 737-893 | Sentence | denotes | To determine directly the roles of Core2GnT in prostate cancer progression, we set up an experimental tumor model using the LNCaP prostate cancer cell line. |
T7 | 894-1051 | Sentence | denotes | Because this line does not express Core2GnT, we established an LNCaP line stably expressing Core2GnT, LNCap-Core2GnT, by transfecting cDNA encoding Core2GnT. |
T8 | 1052-1251 | Sentence | denotes | When mock-transfected LNCaP cells and LNCaP-Core2GnT were inoculated in the prostate of nude mice, LNCaP-Core2GnT cells produced three times heavier prostate tumors than mock-transfected LNCaP cells. |
T9 | 1252-1519 | Sentence | denotes | Furthermore, we found that LNCaP-Core2GnT cells adhered more strongly to prostate stromal cells, type IV collagen and laminin than did LNCaP-mock cells, but LNCaP and LNCaP-Core2GnT cells grew almost at the same rate on plates coated with type IV collagen or laminin. |
T10 | 1520-1630 | Sentence | denotes | These results indicate that Core2GnT is an extremely useful prognostic marker for prostate cancer progression. |
T11 | 1631-1881 | Sentence | denotes | The results also suggest that acquiring Core2GnT in prostate carcinoma cells facilitates adhesion to type IV collagen and laminin, and this increased adhesion may be a cause for aggressive tumor formation by prostate cancer cells expressing Core2GnT. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 14-20 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
T2 | 264-270 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
T3 | 428-434 | Glycan | denotes | core 2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00033MO |
GlyCosmos15-Lectin-Jamboree
Id | Subject | Object | Predicate | Lexical cue | glycosmos_id |
---|---|---|---|---|---|
T1 | 723-726 | Lectin | denotes | PSA | GL_000021 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 556-561 | OrganismTaxon | denotes | human | 9606 |
T2 | 1145-1149 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 73-81 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T2 | 142-158 | Body_part | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL_0000066 |
T3 | 317-323 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/UBERON_0000055 |
T4 | 358-363 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T5 | 368-372 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T6 | 537-545 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T7 | 696-704 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T8 | 784-792 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T9 | 867-875 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T10 | 1128-1136 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T11 | 1201-1209 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T12 | 1325-1347 | Body_part | denotes | prostate stromal cells | http://purl.obolibrary.org/obo/CL_0002622 |
T13 | 1602-1610 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T14 | 1683-1691 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
T15 | 1839-1847 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/UBERON_0002367 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 73-81 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T2 | 317-323 | Body_part | denotes | vessel | http://purl.obolibrary.org/obo/MAT_0000393 |
T3 | 358-363 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/MAT_0000526 |
T4 | 368-372 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/MAT_0000135 |
T5 | 537-545 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T6 | 696-704 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T7 | 784-792 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T8 | 867-875 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T9 | 1128-1136 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T10 | 1201-1209 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T11 | 1325-1333 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T12 | 1602-1610 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T13 | 1683-1691 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |
T14 | 1839-1847 | Body_part | denotes | prostate | http://purl.obolibrary.org/obo/MAT_0000078 |